decitabine,venetoclax
roche,supergen,abbvie,mgi pharma
['award', ' eve ', 'leukemia', 'venetoclax', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'decitabine']
key study describing the outcomes with oral decitabine and venetoclax in older and unfit patients with #aml by out leukemia fellow dr. tareq abouasab, an #ash22 abstract achievement award winner. an all oral regimen 
Tapan Kadia, MD _x000D_
- Leukemia Doc at MD Anderson Cancer Center _x000D_
 Leukemia, clinical/translational research.  Views, posts and opinions shared are my own.